help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, D. G.
Right arrow Articles by Martin, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, D. G.
Right arrow Articles by Martin, W. J., II

Am. J. Respir. Cell Mol. Biol., Vol 17, No. 4, 10 1997, 462-470.

Nonimmune phagocytosis of liposomes by rat alveolar macrophages is enhanced by vitronectin and is vitronectin-receptor mediated

DG Perry, P Wisniowski, GL Daugherty, J Downing and WJ Martin 2nd
Department of Medicine and School of Allied Health Sciences, Indiana University School of Medicine, Indianapolis 46202, USA.

Pulmonary alveolar macrophages (AMs) engulf diverse materials. The mechanisms allowing AMs to recognize, bind, and phagocytose these materials are poorly understood. To test the hypothesis that the adhesive glycoprotein vitronectin (Vn) acts as a nonimmune opsonin, we studied AM-Vn binding and AM phagocytosis of fluorescent liposomes under the following conditions: (1) pretreatment of AMs with Vn, followed by incubation of AMs with liposomes containing increased amounts of Vn; (2) inhibition of phagocytosis by gly-arg-gly-asp-ser (RGD) and gly-pen-gly-arg-gly-asp-ser-pro-cys-ala (GPen); and (3) antibody blockade of the alpha(v)beta3 vitronectin receptor (VnR). Pretreatment of AMs with 0.1, 1, and 2 microM Vn progressively enhanced AM-Vn binding from 23,622 +/- 3,328 cpm to 40,847 +/- 6,530 cpm, 57,149 +/- 2,789 cpm, and 124,852 +/- 42,930 cpm, respectively (P < 0.05). AM pretreatment also increased phagocytosis of Vn-enriched liposomes, but not empty liposomes (20.7 +/- 0.4 liposomes/cell versus 11.5 +/- 0.5 liposomes/cell, P < 0.05). Moreover, increased concentrations of Vn in liposomes progressively increased phagocytic activity (3.7 +/- 0.3, 6.5 +/- 0.2, 11.5 +/- 0.5, and 16.5 +/- 0.6 liposomes/cell with 0.01, 0.1, and 1 microM Vn, respectively, P < 0.05). RGD inhibited Vn-enhanced phagocytosis (8.1 +/- 0.4 liposomes/cell to 3.4 +/- 0.2, 2.4 +/- 0.4, and 2.2 +/- 0.2 liposomes/cell with 0.02, 0.2, and 2 mM RGD, respectively, P < 0.05), as did GPen (4.7 +/- 0.8 liposomes/cell versus control = 10.9 +/- 1.5 liposomes/cell, P < 0.05) and anti-VnR antibody (3.3 +/- 0.4 liposomes/cell versus control = 8.9 +/- 1.7 liposomes/cell, P < 0.05). We conclude that AMs employ Vn as a nonimmune opsonin to enhance the efficiency of phagocytosis.


This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
J. S. Patton, C. S. Fishburn, and J. G. Weers
The Lungs as a Portal of Entry for Systemic Drug Delivery
Proceedings of the ATS, December 1, 2004; 1(4): 338 - 344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. E. WISNIOWSKI, R. W. SPECH, M. WU, N. A. DOYLE, R. PASULA, and W. J. MARTIN II
Vitronectin Protects Alveolar Macrophages from Silica Toxicity
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 733 - 739.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. H. Anderson, G. S. Hageman, R. F. Mullins, M. Neitz, J. Neitz, S. Ozaki, K. T. Preissner, and L. V. Johnson
Vitronectin Gene Expression in the Adult Human Retina
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3305 - 3315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Perry, G. L. Daugherty, and W. J. Martin II
Clathrin-Coated Pit-Associated Proteins Are Required for Alveolar Macrophage Phagocytosis
J. Immunol., January 1, 1999; 162(1): 380 - 386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1997 American Thoracic Society.